Eton Pharmaceuticals, Inc. (ETON)
18.15
+1.16
(+6.83%)
USD |
NASDAQ |
Mar 02, 16:00
18.00
-0.15
(-0.83%)
After-Hours: 20:00
Eton Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -31.22M |
| Johnson & Johnson | -1.369B |
| Vir Biotechnology, Inc. | 1.039M |
| Sensei Biotherapeutics, Inc. | -0.168M |
| Picard Medical, Inc. | 8.949M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.03M |
| Cash from Investing (Quarterly) | -0.284M |
| Free Cash Flow | 12.89M |
| Free Cash Flow Per Share (Quarterly) | 0.4366 |
| Free Cash Flow to Equity (Quarterly) | 11.56M |
| Free Cash Flow to Firm (Quarterly) | 12.94M |
| Free Cash Flow Yield | 2.66% |